|

Encorafenib Pill Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Early 1: 1

Top Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • BRAF V600 Mutation1
  • Melanoma Stage III1
  • Melanoma Stage IV1
  • Cancer1

Tampa, Florida1 trial

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

Moffitt Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.